D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 74,000
+5,300 (7.71%)
Apr 10, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 2.99 trillion as of April 10, 2026. Its market cap has increased by 442.17% in one year.
Market Cap
2.99T
Enterprise Value
2.96T
Revenue
4.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
74,000.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 2.99T, an increase of 687.99%. That is a compound annual growth rate of 189.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 3.22T | -19.39% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 7.45T |
| HLB Co., Ltd. | 6.94T |
| Peptron | 6.48T |
| LigaChem Biosciences | 6.20T |
| Voronoi | 4.91T |
| SK bioscience | 3.16T |
| OliX Pharmaceuticals | 3.16T |
| PharmaResearch | 2.94T |